🇺🇸 FDA
Patent

US 11186577

Vasopressin receptor antagonists and products and methods related thereto

granted A61PA61P15/08A61P15/10

Quick answer

US patent 11186577 (Vasopressin receptor antagonists and products and methods related thereto) held by BLACKTHORN THERAPEUTICS, INC. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BLACKTHORN THERAPEUTICS, INC.
Grant date
Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61P, A61P15/08, A61P15/10, A61P25/18, A61P25/20